Stockscreener 앱 받기
3.35
0.30%
-0.010
전일 마감가:
$3.36
열려 있는:
$3.35
하루 거래량:
1.54M
Relative Volume:
0.67
시가총액:
$329.58M
수익:
$361.07M
순이익/손실:
$-71.54M
주가수익비율:
-4.2405
EPS:
-0.79
순현금흐름:
$-47.97M
1주 성능:
-19.86%
1개월 성능:
-12.76%
6개월 성능:
+3.72%
1년 성능:
+590.72%
1일 변동 폭
$3.335
$3.50
1주일 범위
$3.21
$4.25
52주 변동 폭
$0.44
$4.88
Oncology Institute Inc Stock (TOI) Company Profile
명칭
Oncology Institute Inc
전화
562-735-3226
주소
18000 STUDEBAKER RD, CERRITOS
TOI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
3.35 | 330.56M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
469.29 | 110.40B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
196.74 | 17.69B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.95 | 12.54B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
199.88 | 12.76B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
180.57 | 10.63B | 4.11B | 239.98M | 193.10M | 4.12 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-25 | 개시 | Needham | Buy |
| 2025-07-23 | 개시 | Noble Capital Markets | Outperform |
| 2025-07-16 | 개시 | B. Riley Securities | Buy |
| 2025-05-15 | 개시 | BTIG Research | Buy |
| 2024-02-26 | 재개 | Jefferies | Buy |
| 2022-09-14 | 개시 | Guggenheim | Buy |
| 2022-08-15 | 개시 | Jefferies | Buy |
모두보기
Oncology Institute Inc 주식(TOI)의 최신 뉴스
ETF Watch: Is The Oncology Institute Inc Equity Warrant a potential multi baggerJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - baoquankhu1.vn
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
Market Recap: Will The Oncology Institute Inc stock maintain momentum in 2025 - Bộ Nội Vụ
The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue - MSN
The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook - TradingView — Track All Markets
The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook - The Manila Times
Cancer care group projects growth and first full year of adjusted profit - Stock Titan
Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions? - simplywall.st
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care - GlobeNewswire Inc.
Is Oncology Institute (TOI) Quietly Rewiring Its Edge Around AI Talent And Boardroom Financial Discipline? - Yahoo Finance
The Oncology Institute Announces Leadership Promotions - The Manila Times
The Oncology Institute Announces Promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer - Quiver Quantitative
Is The Oncology Institute Inc. stock a buy before product launchesMarket Performance Report & Risk Controlled Swing Trade Alerts - Улправда
Will The Oncology Institute Inc. stock attract more institutional investorsJuly 2025 Update & Daily Chart Pattern Signal Reports - Улправда
Will The Oncology Institute Inc. stock gain from strong economyMarket Activity Summary & High Conviction Buy Zone Picks - Улправда
Can The Oncology Institute Inc. stock deliver surprise earnings beatMarket Performance Summary & Expert Verified Stock Movement Alerts - Улправда
Will The Oncology Institute Inc. Equity Warrant stock deliver consistent dividendsEarnings Performance Report & Weekly Top Gainers Trade List - Улправда
Can The Oncology Institute Inc. Equity Warrant stock rebound after recent weakness2025 Fundamental Recap & Target Return Focused Picks - Улправда
How The Oncology Institute Inc. Equity Warrant stock trades during market volatilityIndex Update & Weekly Setup with ROI Potential - Улправда
Why The Oncology Institute Inc. Equity Warrant stock could see breakout soonWeekly Market Report & Low Drawdown Investment Ideas - Улправда
The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard - The Globe and Mail
Oncology Institute Adds Independent Director and Audit Chair - TipRanks
For Oncology Institute Insiders, Selling US$644k Of Shares Was A Smart Move - simplywall.st
The Oncology Institute Announces Addition of Board Member Mark Stolper - marketscreener.com
Cancer care group adds veteran CFO to its board of directors - Stock Titan
Can The Oncology Institute Inc. Equity Warrant stock sustain free cash flow growth2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Will The Oncology Institute Inc. Equity Warrant stock reach Wall Street targetsJuly 2025 Recap & Expert Approved Trade Ideas - Улправда
Will The Oncology Institute Inc. stock gain from government policiesMarket Growth Report & Momentum Based Trading Signals - Улправда
Is The Oncology Institute Inc. Equity Warrant stock a top pick in earnings seasonJuly 2025 Action & Low Risk Profit Maximizing Plans - Улправда
How institutional buying supports The Oncology Institute Inc. stockEarnings Trend Report & Weekly Momentum Stock Picks - Bölüm Sonu Canavarı
How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesPortfolio Growth Summary & Weekly Market Pulse Updates - Улправда
Take Profit: Will The Oncology Institute Inc. Equity Warrant stock benefit from infrastructure spending2025 Price Action Summary & Technical Pattern Alert System - ulpravda.ru
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute - Sahm
How The Oncology Institute Inc. Equity Warrant stock performs in stagflationShare Buyback & Fast Gain Swing Trade Alerts - DonanımHaber
Update Recap: How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesJuly 2025 Intraday Action & Consistent Profit Focused Trading Strategies - Улправда
Will The Oncology Institute Inc. Equity Warrant stock keep outperforming rivalsMarket Performance Report & Daily Technical Forecast Reports - DonanımHaber
The Oncology Institute: Making Progress (NASDAQ:TOI) - Seeking Alpha
Is The Oncology Institute Inc. stock supported by strong fundamentals2025 Pullback Review & Community Consensus Trade Signals - Улправда
Brad Hively Sells 13,333 Shares of Oncology Institute (NASDAQ:TOI) Stock - MarketBeat
Oncology Institute Director Sells Shares to Cover Tax Liabilities - TradingView — Track All Markets
Officer/Dir Hively Surrenders 13,333 Of Oncology Institute Inc [TOI] - TradingView — Track All Markets
TOI (NASDAQ: TOI) notice covers planned Rule 144 sale of 13,333 shares - Stock Titan
MSN Money - MSN
Wall Street analysts’ outlook for Oncology Institute Inc (TOI) - setenews.com
Can The Oncology Institute Inc. Equity Warrant stock deliver strong Q4 earnings2025 Short Interest & Growth Focused Entry Point Reports - Newser
How The Oncology Institute Inc. Equity Warrant stock compares to market leadersMarket Sentiment Report & Weekly Sector Rotation Insights - Newser
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
This trade activity should not be overlooked: Oncology Institute Inc (TOI) - setenews.com
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute - Yahoo Finance
Why The Oncology Institute Inc. Equity Warrant stock could benefit from AI revolutionPortfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Is The Oncology Institute Inc. Equity Warrant stock a safe investment in uncertain marketsQuarterly Performance Summary & High Accuracy Swing Entry Alerts - Newser
Oncology Institute Inc (TOI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.22%
자본화:
|
볼륨(24시간):